Patents by Inventor Michael Dey

Michael Dey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutical composition containing apomorphine as active ingredient
    Patent number: 11766431
    Abstract: A pharmaceutical composition contains apomorphine as the active pharmaceutical ingredient, a water-miscible co-solvent, an antioxidant, and water. The solution has a pH greater than 4. The pharmaceutical composition is suitable for parenteral administration for the treatment of Parkinson's disease. The process for the manufacture of the pharmaceutical composition includes weighing the apomorphine and introducing it into a container with the co-solvent and the antioxidant under agitation until complete dissolution takes place.
    Type: Grant
    Filed: April 30, 2021
    Date of Patent: September 26, 2023
    Assignee: Britannia Pharmaceuticals Ltd.
    Inventors: Michael Dey, Joel Richard, Marie-Madeleine Baronnet, Nathalie Mondoly, Laurent Bertocchi, Jeremiah Harnett
  • NEW THERAPEUTICAL COMPOSITION CONTAINING APOMORPHINE AS ACTIVE INGREDIENT
    Publication number: 20210244724
    Abstract: A pharmaceutical composition contains apomorphine as the active pharmaceutical ingredient, a water-miscible co-solvent, an antioxidant, and water. The solution has a pH greater than 4. The pharmaceutical composition is suitable for parenteral administration for the treatment of Parkinson's disease. The process for the manufacture of the pharmaceutical composition includes weighing the apomorphine and introducing it into a container with the co-solvent and the antioxidant under agitation until complete dissolution takes place.
    Type: Application
    Filed: April 30, 2021
    Publication date: August 12, 2021
    Inventors: Michael Dey, Joel Richard, Marie-Madeleine Baronnet, Nathalie Mondoly, Laurent Bertocchi, Jeremiah Harnett
  • Therapeutical composition containing apomorphine as active ingredient
    Patent number: 11026938
    Abstract: A pharmaceutical composition contains apomorphine as the active pharmaceutical ingredient, a water-miscible co-solvent, an antioxidant, and water. The solution has a pH greater than 4. The pharmaceutical composition is suitable for parenteral administration for the treatment of Parkinson's disease. The process for the manufacture of the pharmaceutical composition includes weighing the apomorphine and introducing it into a container with the co-solvent and the antioxidant under agitation until complete dissolution takes place.
    Type: Grant
    Filed: January 10, 2014
    Date of Patent: June 8, 2021
    Assignee: Britannia Pharmaceuticals Ltd.
    Inventors: Michael Dey, Joel Richard, Marie-Madeleine Baronnet, Nathalie Mondoly, Laurent Bertocchi, Jeremiah Harnett
  • THERAPEUTICAL COMPOSITION CONTAINING APOMORPHINE AS ACTIVE INGREDIENT
    Publication number: 20180098981
    Abstract: A pharmaceutical composition contains apomorphine as the active pharmaceutical ingredient, a water-miscible co-solvent, an antioxidant, and water. The solution has a pH greater than 4. The pharmaceutical composition is suitable for parenteral administration for the treatment of Parkinson's disease. The process for the manufacture of the pharmaceutical composition includes weighing the apomorphine and introducing it into a container with the co-solvent and the antioxidant under agitation until complete dissolution takes place.
    Type: Application
    Filed: December 13, 2017
    Publication date: April 12, 2018
    Applicant: BRITANNIA PHARMACEUTICALS LTD.
    Inventors: Michael DEY, Joel RICHARD, Marie-Madeleine BARONNET, Nathalie MONDOLY, Laurent BERTOCCHI, Jeremiah HARNETT
  • THERAPEUTICAL COMPOSITION CONTAINING APOMORPHINE AS ACTIVE INGREDIENT
    Publication number: 20160310480
    Abstract: A pharmaceutical composition contains apomorphine as the active pharmaceutical ingredient, a water-miscible co-solvent, an antioxidant, and water. The solution has a pH greater than 4. The pharmaceutical composition is suitable for parenteral administration for the treatment of Parkinson's disease. The process for the manufacture of the pharmaceutical composition includes weighing the apomorphine and introducing it into a container with the co-solvent and the antioxidant under agitation until complete dissolution takes place.
    Type: Application
    Filed: June 30, 2016
    Publication date: October 27, 2016
    Inventors: Michael Dey, Joel Richard, Marie-Madeleine Baronnet, Nathalie Mondoly, Laurent Bertocchi, Jeremiah Harnett
  • NEW THERAPEUTICAL COMPOSITION CONTAINING APOMORPHINE AS ACTIVE INGREDIENT
    Publication number: 20140128422
    Abstract: A pharmaceutical composition contains apomorphine as the active pharmaceutical ingredient, a water-miscible co-solvent, an antioxidant, and water. The solution has a pH greater than 4. The pharmaceutical composition is suitable for parenteral administration for the treatment of Parkinson's disease. The process for the manufacture of the pharmaceutical composition includes weighing the apomorphine and introducing it into a container with the co-solvent and the antioxidant under agitation until complete dissolution takes place.
    Type: Application
    Filed: January 10, 2014
    Publication date: May 8, 2014
    Applicant: Britannia Pharmaceuticals Ltd.
    Inventors: Michael Dey, Joel Richard, Marie-Madeleine Baronnet, Nathalie Mondoly, Laurent Bertocchi, Jeremiah Harnett